Subscribe
Ep. 77: Data Ethics and Compliance – Wendy M. Charles, PhD, CIP, CCRP, CBP

Health Unchained

Ep. 77: Data Ethics and Compliance – Wendy M. Charles, PhD, CIP, CCRP, CBP

Wendy M. Charles, PhD, CIP, CCRP, CBP is a resear…
December 5, 2020
ADVERTISEMENT

Ep. 77: Data Ethics and Compliance – Wendy M. Charles, PhD, CIP, CCRP, CBP

Wendy M. Charles, PhD, CIP, CCRP, CBP is a researcher and regulatory compliance scientist with expertise in managing clinical research operations, quality assurance, and implementation of health information technologies. She has 28 years of research experience; 16 years of management experience with industry-sponsored and federally funded research. Wendy is Chief Scientific Officer at BurstIQ, co-chair of the IEEE Standards Development Working group for blockchain in healthcare and life sciences, and has contributed to numerous other blockchain/healthcare publications.

BurstIQ Website: www.burstiq.com

Blockchain Compliance by Design: Regulatory Considerations for Blockchain in Clinical Research: https://www.frontiersin.org/articles/10.3389/fbloc.2019.00018/full

We talk about how we can start encouraging an ethics by design approach to building software and how dynamic consent management can provide more control over a patient’s own health data.

Related episode: https://soundcloud.com/healthunchained/ep-56-securing-health-connections-frank-ricotta-ceo-burstiq

IEEE HEALTHCARE VIRTUAL SERIES: BLOCKCHAIN & AI: https://attend.ieee.org/healthcare-blockchain-ai/

Show Notes

•Introduction to Wendy’s background
•What drove you to the healthcare world?
•How did you first hear about blockchain technology?
•How does your academic research experience influence your perspectives in healthcare infotech industry?
•Digital tattoos for temporary health monitoring
•Impact of COVID-19 on Clinical research operations
•Importance of Ethics by Design
•World leadership summit link – https://worldleadersummit.com/topicscategories/blockchain/
•Dynamic Consent management, broad and specific consent
•Describe your role as CSO at BurstIQ
•What tactics is BurstIQ employing to address data privacy and personal ownership of one’s data?
•Customers like Intermountain Healthcare saved ~$90M over three years by using BurstIQ: https://www.burstiq.com/burstiq-brings-90-million-case-study-to-blockchain-through-intermountain-healthcare-spin-off-empiric-health/
•What are the biggest barriers to blockchain adoption in healthcare?
•Balancing between regulatory compliance and technology innovation
•Most influential book you’ve read – The Patient Will See You Now by Dr. Eric Topol
•What are your thoughts about the singularity that is supposed to happen in 2045?
•If you had to have micro chip implanted in your body, where would you want it to be implanted?
•Thoughts on Neuralink technology
•Final Takeaways

News Corner

https://deepmind.com/blog/article/alphafold-a-solution-to-a-50-year-old-grand-challenge-in-biology
Alphabet’s decade old DeepMind artificial intelligence system has essentially solved a 50 year old grand challenge in biology. That problem is known as the protein folding problem. Proteins are the building blocks and operate all our functional biology systems. They are large complex molecules made up of chemical chains and amino acids. This is important because, right now, in order to figure out how a specific protein looks like and how it physically conforms in 3D space, scientists typically use X-Ray crystallography techniques which costs over $100k and takes up to a year to complete. There are currently over 200 million proteins in the main database and only about 170,000 have their 3D structures mapped out, a fraction of the 200M. This research is currently being peer-reviewed for final publication and scientists are absolutely excited about exploring this amazing technology for the advancement of scientific knowledge.

Health Unchained Links
Website: https://healthunchained.org
Telegram: t.me/healthunchained
Twitter: twitter.com/Healthunchaind

ADVERTISEMENT
TransferWise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.